Arbutus Biopharma Corp (NASDAQ:ABUS)
| 4.64 BATS BZX Real-Time Price As of 3:45pm ET |  +0.135 / +2.99%Today’s Change | 2.43 Today|||52-Week Range 5.87 | +30.85% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 4.51 |
| Today’s open | 4.52 |
| Day’s range | 4.45 - 4.69 |
| Volume | 82,382 |
| Average volume (3 months) | 2,028,594 |
| Market cap | $431.4M |
Data as of 3:45pm ET, 09/24/2021
Growth & Valuation
| Earnings growth (last year) | +65.36% |
| Earnings growth (this year) | +10.40% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +15.02% |
| P/E ratio | NM |
| Price/Sales | 38.94 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EOLSEvolus Inc | -0.23 | -2.85% |
| MRNSMarinus Pharmaceutic... | -0.32 | -2.57% |
| ---- | ||
| SVASinovac Biotech Ltd | -- | -- |
Data as of 3:46pm ET, 09/24/2021
Financials
| Next reporting date | November 10, 2021 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$63.7M |
| Net profit margin | -921.97% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
